Identification of Neisseria meningitidis sequence type 66 in Poland

Clinical Microbiology and Infection

Volumn 10, Issue 9, 2004, Pages 848-850

  Skoczynska, A ^a   Konior, R ^b   Sadowy, E ^a   Piatkowska Smietanska, M ^b   Lelek, B ^b   Gniadkowski, M ^a   Hryniewicz, W ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Epidemiology; Meningitis; Neisseria meningitidis; Typing

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BELGIUM; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CLINICAL OBSERVATION; FAMILY; GENE LOCUS; GENETIC VARIABILITY; HUMAN; MALE; MENINGOCOCCOSIS; MOLECULAR CLONING; NEISSERIA MENINGITIDIS; NEW ZEALAND; NONHUMAN; PHENOTYPE; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPAIN;

NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 4644293703     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1198-743X.2004.00941.x     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention and control of meningococcal disease. MMWR 2000; 49(RR-07): 1-10.
2. Verdu ME, Coll P, Fontanals D ef al. Endemic meningococcal disease in Cerdanyola, Spain, 1987-93: molecular epidemiology of the isolates of Neisseria meningitidis. Clin Microbiol Infect 1996; 2: 168-178.
3. Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-525.
4. Vogel U, Morelli G, Zurth K et al. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol 1998; 36: 2465-2470.
5. Cartwright K. Meningococcal carriage and disease. In: Cartwright K, ed. Meningococcal disease. Chichester: Wiley, 1995; 115-146.
6. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-371.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, twelfth informational supplement. NCCLS document M100-S12. Wayne, PA: NCCLS, 2000.
8. Woods JP, Kersulyte D, Tolan RW, Berg CM, Berg DE. Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak. J Infect Dis 1994; 169: 1384-1389.
9. Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 514-520.
10. Feavers IM, Gray SJ, Urwin R et al. Multilocus sequence typing and antigen sequencing in the investigation of a meningococcal disease outbreak. J Clin Microbiol 1999; 37: 3883-3887.
11. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-3145.
12. Hammerschmidt S, Muller A, Sillmann H et al. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 1996; 20: 1211-1220.
13. van Looveren M, Caugant DA, Chapelle S, Carion F, Goossens H. Interpreting the rising incidence of meningococcal disease in Belgium: the contribution of molecular typing. J Med Microbiol 2001; 50: 986-990.